Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...
Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengths Two differentiated treatments exemplify ...
Stimulant drugs and another medication – atomoxetine – appear to be the best treatment for managing symptoms of ADHD, a study suggests. Monique Wüstenhagen/dpa Talking therapy and brain stimulation ...
SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug ...
Do you suspect you or your loved ones have ADHD? Are you struggling with attention, focus, or hyperactivity? Are your symptoms starting to negatively impact your performance at school, work or even in ...
Despite decades of research, these ADHD myths still affect how people understand attention and behavior.
General practitioners in Victoria will soon be able to diagnose and treat ADHD in adults and children in a move the state ...
Following the changes made today, more New Zealanders with ADHD will have faster access to support as a result of changes to ...
SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results